ESR1 and breast carcinoma: The breast cancer cell lines MCF7 and T47D are very sensitive to a selection of antihormonal drugs (Fig. 6c), which prompted us to investigate whether ESR1, PGR, and GREB1 protein show similar abundance profiles across the NCI60 panel as their p-sites.